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Abstract
Aims
The usefulness of mortality statistics relies on the validity of death certificate diagnosis.
However, diagnosing the causal sequence of conditions leading to death is not simple. We
examined diagnostic support for fatal acute myocardial infarction (AMI) and investigated its
association with regional variation.
Methods and results
From Danish nationwide registers, we identified the study population (N = 3,244,051) of
whom 36,669 individuals were recorded with AMI as the underlying cause-of-death between
2002 and 2015. We included clinical diagnoses, procedures, and claimed prescriptions
related to atherosclerotic disease to evaluate the level of diagnostic support for fatal AMI in
three diagnostic groups (Definite; Plausible; Uncertain). Adjusted mortality rates, rate ratios,
and odds ratios were estimated for each AMI category, stratified by hospital region using
multivariable regression models. More than one-third (N = 12,827, 35%) of deaths reported
as fatal AMI had uncertain diagnostic support. The largest regional variation in AMI mortality
rate ratios, varying from 1.16 (95%CI:1.02;1.31) to 1.62 (95%CI:1.43;1.83), was found
among cases with uncertain diagnostic supportive data. Substantial inter-regional differ-
ences in the degree to which death occurs outside hospital [OR: 1.01 (95%CI:0.92;1.12) -
1.49 (95%CI:1.36;1.63)] and general practitioners determining the cause-of-death at home
were present. Minor regional differences [OR: 0.96 (95%CI:0.85;1.07) - 1.16 (95%
CI:1.04;1.29)] in in-hospital AMI mortality were observed.
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Conclusion
There is significant regional variation associated with recording AMI as a cause-of-death.
This variation is predominately based on death certificate diagnoses without diagnostic sup-
portive evidence. Studies of fatal AMI should include a stratification on supportive evidence
of the diagnosis.
Introduction
Cause-of-death statistics derived from death certificates are important for monitoring epide-
miologic patterns and developing new healthcare strategies. However, critically, the usefulness
of mortality statistics depends on their quality, which varies [1–3]. To ensure valid compari-
sons within and between countries, clear and detailed diagnostic classification groups have
been developed in the International Classification of Diseases (ICD) [4]. Nevertheless, substan-
tial regional variation in death from ischemic heart disease (IHD) is present [5–8]. Whether
low validity of the cause-of-death statements in death certificates is responsible for the varia-
tion remains unexplored.
Mortality statistics rely on the coding done by the individual physicians in which the under-
lying cause-of-death is estimated with some degree of uncertainty when an autopsy is not per-
formed. Physicians are responsible for stating which morbid condition led directly to death
and indicating any preceding conditions giving rise to this cause [9]. Yet, in everyday practice,
diagnosing the causal sequence of conditions leading to death is not simple. The data available
for the physicians producing the death certificates may vary markedly. The physician may
have a hospital file with multiple diagnostic information or, at the other extreme, the physician
may have hardly any information. Coding practices in the latter case could, in principle,
markedly influence the mortality rate of reported acute myocardial infarction (AMI) and
other diseases that physicians are inclined to diagnose when there is little clinical information
available.
Misclassification with respect to death certificate completion has been found to be very
high, ranging from 25% to 78% in hospital-based studies [10–13], and from 16% to 56% in
population-based studies [14–16]. Age, speciality, training, and skills of certifiers are important
predictors of misclassification [16]. The influence on mortality statistics has been observed to
be particularly high in countries where residents predominantly die outside the hospital and
where the autopsy rate is low [17]. In Denmark, at present, the autopsy rate is below 10% [9,
18]. A relatively high sensitivity of AMI in Danish mortality statistics compared to clinical rec-
ords has previously been reported [19]. Yet international studies have expressed concern
about the quality of data from death certificates for analysing mortality related to IHD [20].
Coronary heart disease appears to be over-diagnosed. In cases of sudden death it was found
that the reported cause-of-death had to be changed in 30% of cases after an autopsy was per-
formed, and in 50% of cases where the underlying cause-of-death was reported as IHD, there
was no basis for this diagnosis [17].
Regional variation in mortality from AMI could be due to genetic factors, lifestyle, and
sociocultural heterogeneity, but could also reflect variability in coding practice. To address this
issue, we examined the prevalence of low diagnostic support for fatal AMI in a nationwide
sample of 3,244,051 Danish residents and studied whether cases with uncertain diagnostic sup-
portive data impact upon regional variability in incidence in mortality from AMI. Time trends
in AMI mortality with respect to diagnostic support and certifier practice were further
addressed.
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Methods
Data sources
In Denmark, all residents are registered with a personal and permanent civil registration num-
ber that enables individual-level linkage of nationwide administrative registries. Since the
majority of all hospital- and general-practitioner-based medical care in Denmark is reim-
bursed by the national health authorities, these administrative registries enable accurate popu-
lation-based studies with national coverage and high levels of completeness [21]. Information
on date and place of death, autopsy, and the cause-of-death classified according to the ICD
was obtained from the Danish Registry of Causes of Death [9]. From the National Patient Reg-
istry we obtained data from patient records including information on all somatic admissions,
procedure codes, and discharge diagnoses classified according to the 10th revision of the ICD
[22]. We obtained information on all prescription medicines dispensed, classified according to
the Anatomical Therapeutic Chemical (ATC) classification system, from the Danish National
Prescription Registry. Drug expenses are partially reimbursed by the Danish Health Authori-
ties, providing a valid and accurate register [23]. From the Danish National Health Service
Register for Primary Care we identified death certificate registrations completed by general
practitioners using reimbursement for the registration disbursed to the general practitioners
[24]. Date of birth, vital status and official residence were obtained from the Central Personal
Registry [25].
Study population and study variables
In this nationwide, register-based cohort study, the study population comprised the total Dan-
ish population (N = 3,244,051) aged 35 years or older registered in the Civil Registration Sys-
tem January 1, 2002. From the study population we identified individuals recorded with AMI
(ICD-10: I21-I22) as the underlying cause-of-death (N = 36,667) within the observation period
from 1 January 2002 to 31 December 2015. To assess diagnostic support for fatal AMI we
examined these deaths using individually based comparison of death certificates with hospita-
lisations and discharge diagnoses, surgery, outpatient procedures, and prescriptions related to
IHD.
Discharge diagnoses comprised all ischemic-related heart diseases (ICD-10: I20-I25)
including among others angina pectoris, acute coronary thrombosis, and chronic IHD. Fur-
thermore, coronary-artery-related surgical procedures (Procedure code: KNF) such as coro-
nary artery bypass grafting and percutaneous coronary intervention were used as proxies for
former ischemic-related heart disease. Hospitalised patients only recorded with suspicion of
AMI were likewise identified (ICD: Z034). The medication was restricted to comprise pharma-
ceuticals prescribed on the indication of acute IHD, namely Nitrates (ATC: C01DA02) and
dual antiplatelet therapy (DAPT). DAPT was defined as concomitant use of low-dose acetyl
salicylic acid, Aspirin (ATC: B01AC06), and a P2Y12 antagonist. Currently, three P2Y12 antag-
onists are available in Denmark: Clopidogrel (ATC: B01AC04), Prasugrel (ATC: B01AC22),
and Tricagrelor (ATC: B01AC24). Therapy use was defined as having filled prescriptions
within 180 days prior to death.
Diagnostic support for fatal AMI
Based on the extent of diagnostic support for fatal AMI, the study population was allocated in
one of three diagnostic AMI groups: Definite; Plausible; Uncertain. Patients who underwent
autopsy or were formerly diagnosed with AMI (ICD-10: I21-I22), who died within 30 days
from AMI hospitalisation were categorised as Definite AMI. Conversely, those who died more
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than 30 days from AMI hospitalisation, those who claimed prescriptions of Nitrates or DAPT,
or were formerly diagnosed with an IHD diagnosis (ICD-10: I20-I25) other than AMI, or had
surgery related to IHD, or were diagnosed with only suspicion of AMI (ICD-10: Z034) were
categorised as Plausible AMI. All other individuals, without diagnostic support related to IHD,
were classified as Uncertain AMI.
Outcome, exposure, and potential confounders
The primary outcome of interest was the extent of diagnostic support, estimating the risk of
AMI death defined with respect to the three diagnostic AMI groups (Definite; Plausible;
Uncertain). A secondary outcome included whether the general practitioner reported AMI as
the underlying cause-of-death, identified by invoices from primary care institutions (invoice
number: 2131 and/or 2135). The main exposures were the five official Danish regions respon-
sible for hospital services (North; Central; South; Zealand; Capital). In each region, dedicated
and invasive coronary care units with specialists in cardiology and accessibility to diagnostic
methods exist. In Denmark, the healthcare system is organised through three administrative
levels: state, region, and local. The state holds the overall responsibility for regulation to ensure
high standard of care, evidence-based treatment, and up-to-date treatment in all regions. Reg-
ulation takes place through, among other things, national guidelines and national quality mon-
itoring systems [26]. Place of death was handled as a potential confounder and was categorised
into death outside hospital (place of death: residential address; known address; unknown
address) or death in hospital. We also estimated comorbidity by calculating a 10-year Charlson
Comorbidity Index score [27] based on hospital discharge diagnosis codes 10 years before
death and antidiabetic medication (ATC: A10) 180 days before death, divided into two groups
(low/moderate (score:0–2); high (score:�3)). Potential confounders also included age at death,
sex, and calendar-year.
Statistics
Categorical variables are presented using percentages and continuous variables using medians
with the 25th (Q1) and 75th (Q3) percentiles. Chi-square and Kruskal-Wallis tests were per-
formed to test differences between diagnostic AMI groups. Age-standardised specific mortality
rates per 100,000 person years for each of the three diagnostic AMI groups by gender and
region were calculated with direct age-standardisation to the European standard population
[28]. Corresponding confidence intervals (95%) were calculated assuming a Poisson distribu-
tion. Mortality rate ratios for the different Danish regions, adjusted for age, sex, and calendar-
year were computed using negative binomial regression analysis. To evaluate trends in specific
mortality of the three AMI groups, we estimated the average annual change using linear
regression models. Odds ratios describing the risk of Definite, Plausible, and Uncertain AMI,
compared to the reference all-cause mortality (exclusive death from AMI) among all deaths in
the study population, across regions were estimated using multinomial logistic regression
models. Multinomial logistic regression analysis was further used to estimate absolute risks of
fatal AMI. We tested for interaction using the likelihood ratio test. Significant interactions
were found between region and place of death and, therefore, we stratified our analyses. Odds
ratios describing differences in general practitioners reporting AMI as underlying cause-of-
death across regions among death from AMI were assessed using logistic regression. A two-
sided P-value <0.05 was considered statistically significant. Analyses were performed using
SAS (version 9.4, SAS Institute, Cary, NC, USA), and R statistical software (version 3.3.2, R
Development Core Team) [29].
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Ethics
This study was approved by the Danish Data Protection Agency (2008-58-0025, local refer-
ence: 2016–3). According to Danish legislation, application for ethical approval is not required
for registry-based studies.
Results
During the study period from 2002 to 2015, 46,721 citizens aged 35 years or older were
recorded in the Danish Registry of Cause-of-death with AMI as the underlying (N = 36,667 or
78.5%) or contributory (N = 10,052 or 21.5%) cause-of-death. Among the 36,667 citizens
recorded with AMI as the underlying cause-of-death, 56.3% occurred in men, 54.2% occurred
in hospitals, and the median age at death in the study population was 80.5 [Q1,Q3: 71.3, 87.1].
The most frequently used contributory causes of death in relation to AMI as the underlying
cause-of-death were AMI without specification (ICD-10: I219), followed by atherosclerotic
heart disease (ICD-10: I251) and atherosclerosis without specification (ICD-10: I701).
Diagnostic support for fatal AMI
Based on diagnostic supportive data for fatal AMI, the 36,667 citizens recorded with AMI as
the underlying cause-of-death were categorised according to diagnostic AMI groups (Definite;
Plausible; Uncertain). A total of 36.3% (N = 13,317) citizens were categorised as Definite AMI
(died within 30 days from AMI hospitalisation), 28.7% (N = 10,525) as Plausible AMI (ante-
cedent conditions, procedures or claimed prescriptions related to IHD), whereas 35%
(N = 12,827) were classified as Uncertain AMI (no diagnostic supportive data related to IHD).
AMI mortality stratified by diagnostic support is summarised in Table 1. When AMI as a con-
tributory cause-of-death was included in the analysis, the percentage-wise distribution of AMI
categorisation was almost the same. The median age at death (78.5 (Q1, Q3: 67.2, 86.5)) for
Uncertain AMI diagnosis was significantly lower compared to other diagnostic AMI groups
(P< 0.0001). Residents without diagnostic support for AMI also presented with markedly
fewer comorbidities and claimed prescriptions (P< 0.0001).
Regional variation in diagnostic support for fatal AMI
Mortality rate ratios (MRR), adjusted for sex, age, and calendar-year showed significant
regional variability in total AMI mortality with ratios of regions ranging from 1.16 (95%
CI:1.02;1.33) to 1.47 (95%CI:1.29;1.68), compared to the largest region, the Capital Region of
Denmark (reference); [Zealand: MRR: 1.22 (95%CI:1.07;1.39)]; [South: MRR: 1.16 (95%
CI:1.02;1.33)]; [Central: MRR: 1.22 (95%CI:1.07;1.39)]; [North: MRR: 1.47 (95%
CI:1.29;1.68)]). The age-standardised mortality rates of the three diagnostic AMI classification
groups, stratified by sex and hospital region, are plotted in Fig 1. Plots with corresponding con-
fidence intervals are available in the data supplement (S1 Fig). The largest regional variation in
death from fatal AMI was found among the 12,827 individuals who lacked diagnostic support
for fatal AMI (Uncertain AMI) with all regions differing significantly from the reference and
MRR of regions varying from 1.16 (95%CI:1.02;1.31) to 1.62 (95%CI:1.43;1.83) compared to
the Capital Region of Denmark (reference) (Fig 2). In contrast, the lowest regional variation in
fatal AMI cases was observed in residents who died within 30 days from AMI hospitalisation
(Definite AMI), with regional MRR ranging from 1.08 (95%CI:0.96;1.21) to 1.28 (95%
CI:1.13;1.44), compared to the Capital Region of Denmark (reference) (Fig 2).
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Time trends in AMI mortality
From 2002 to 2015, the age-standardised mortality rate from AMI per 100,000 person years
declined in men from 123.4 (95%CI:118.2;128.8) to 45.5 (95%CI:42.7;48.6) and in women
from 67.4 (95%CI:64.3;70,5) to 20 (95%CI:18,4;21.7) (Table 2). A substantial decline in mortal-
ity rates (annual change) was observed across all three diagnostic AMI classification groups
and for both sexes, with the greatest declines in individuals classified as Definite AMI
(Table 2). In addition, the total AMI mortality rate fell the most (annual change) among
patients who died in hospital compared to residents who died outside the hospital.
Regional differences in place of death
When place of death was included in the adjusted multinomial regression analysis (con-
founders: sex, age at death, calendar-year, comorbidity, place of death), estimating risk of
AMI death with respect to diagnostic AMI groups, a significant interaction between region
and place of death was observed (P< 0.0001). Therefore, the analyses were repeated strati-
fied on place of death. The stratified analysis showed significant regional variation in AMI
Table 1. Demographic stratification according to diagnostic support for fatal acute myocardial infarction.
Definite AMI (n = 13,317) Plausible AMI (n = 10,525) Uncertain AMI (n = 12,827) Total (n = 36,669) p-value
Sex
Women 6108 (45.9) 4164 (39.6) 5747 (44.8) 16019 (43.7)
Men 7209 (54.1) 6361 (60.4) 7080 (55.2) 20650 (56.3) <0.0001
Median [Q1,Q3] age [years] 81.4 (73.6,87.1) 81.4 (73.3,87.6) 78.5 (67.2,86.5) 80.5 (71.3,87.1) <0.0001
Place of death
Outside hospital 921 (6.9) 4751 (45.1) 6541 (51.0) 12213 (33.3)
Hospital 12138 (91.1) 4097 (38.9) 3645 (28.4) 19880 (54.2)
Unknown 258 (1.9) 1677 (15.9) 2641 (20.6) 4576 (12.5) <0.0001
Comorbidity
Stroke 3285 (24.7) 2759 (26.2) 2119 (16.5) 8163 (22.3) <0.0001
Peripheral artery disease 1970 (14.8) 1724 (16.4) 923 (7.2) 4617 (12.6) <0.0001
Heart failure 5305 (39.8) 4977 (47.3) 1651 (12.9) 11933 (32.5) <0.0001
Hypertension 5118 (38.4) 4482 (42.6) 3028 (23.6) 12628 (34.4) <0.0001
Atrial fibrillation 2881 (21.6) 3333 (31.7) 1770 (13.8) 7984 (21.8) <0.0001
Diabetes 2655 (19.9) 2127 (20.2) 1261 (9.8) 6043 (16.5) <0.0001
Cancer 2103 (15.8) 1777 (16.9) 1812 (14.1) 5692 (15.5) <0.0001
Medicine
Nitrates 3627 (27.2) 4482 (42.6) 0 (0.0) 8109 (22.1) <0.0001
Beta Blockers 4936 (37.1) 5320 (50.5) 2224 (17.3) 12480 (34.0) <0.0001
Lipid lowering medications 3729 (28.0) 4316 (41.0) 1582 (12.3) 9627 (26.3) <0.0001
Aspirins 6800 (51.1) 6977 (66.3) 3450 (26.9) 17227 (47.0) <0.0001
Antiplatelets 1460 (11.0) 1296 (12.3) 139 (1.1) 2895 (7.9) <0.0001
Calcium antagonists 3728 (28.0) 2646 (25.1) 2343 (18.3) 8717 (23.8) <0.0001
ACE-inhibitors 5147 (38.6) 5170 (49.1) 3467 (27.0) 13784 (37.6) <0.0001
Diuretics 7645 (57.4) 7457 (70.9) 5613 (43.8) 20715 (56.5) <0.0001
Antidiabetics 2267 (17.0) 1841 (17.5) 1285 (10.0) 5393 (14.7) <0.0001
Characteristics of residents (N = 36,669) aged�35 years or older, recorded with acute myocardial infarction (AMI) as the underlying cause-of-death by diagnostic
support for fatal AMI. Data are presented as median with interquartile range (age) or number of residents and percentage (all others).
https://doi.org/10.1371/journal.pone.0236322.t001
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cases without supportive data occurring outside the hospital in three out of four regions,
with odds ratios of risk of death from AMI within regions ranging from 1.01 (95%
CI:0.92;1.12) to 1.49 (95%CI:1.36;1.63), compared to the Capital Region of Denmark (refer-
ence) (Fig 3). Among residents who died in hospital, the variability across regions in indi-
viduals without diagnostic support for fatal MI was lower with odds ratios of risk of death
from AMI within regions varying from 0.96 (95%CI:0.85;1.07) to 1.16 (95%CI:1.04;1.29)
(Fig 3). The predicted absolute risks of death from AMI without supportive data across
regions, stratified on place of death, showed higher risk of death from AMI outside hospital
and larger variability in death from AMI across regions outside hospital, compared to AMI
death without supportive data in hospital (Fig 4).
Geographic variation in certifier practice
In logistic regression analysis, adjusted for age, sex, and calendar-year, significant inter-
regional differences in general practitioners reporting AMI as underlying cause-of-death were
observed compared to the Capital Region of Denmark (reference): [Zealand: OR: 1.13 (95%
CI:1.05;1.22)]; [South: OR: 1.35 (95%CI:1.26;1.44)]; [Central: OR: 1.55 (95%CI:1.46;1.66);
[North: OR: 1.67 (95%CI:1.56;1.80)].
Fig 1. Age-standardised mortality rates from acute myocardial infarction by region and diagnostic support. Age-standardised mortality rates from acute
myocardial infarction (AMI) per 100,000 population, stratified by gender and by diagnostic support for fatal AMI, for each official Danish region (N = 36,669).
https://doi.org/10.1371/journal.pone.0236322.g001
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Discussion
The main result of this nationwide study is that nearly four in ten individuals recorded with
AMI as the underlying cause-of-death lacked diagnostic support for fatal AMI. The pro-
nounced regional variability in death from AMI, with nearly 50% higher risk of a fatal outcome
of AMI in some regions, is predominantly driven by cases without diagnostic supportive data.
An uneven regional distribution of fatal AMI cases without supportive data occurring outside
hospital was found, whereas minor regional differences in in-hospital AMI mortality were
observed.
A possible explanation for the significant regional differences in fatal AMI outcome is mis-
classification of AMI as cause-of-death. In support of our findings, a recent study on geograph-
ical variation in fatal outcome of AMI demonstrated no geographical inequality in AMI
mortality among patients who survived 28 days after AMI diagnosis [7]. The lack of regional
differences in AMI incidence rates strongly support our hypothesis of misclassification of AMI
as a cause-of-death when limited diagnostic supportive data are present. Regional differences
in standard of treatment and procedures including, among other things, accessibility to spe-
cialised coronary care units and diagnostic techniques could potentially lead to unequal death
Fig 2. Standardised mortality rate ratios from acute myocardial infarction by diagnostic support and region. Forrest plot presenting standardised mortality
rate ratios from acute myocardial infarction (AMI) by diagnostic support for fatal AMI with their 95% confidence intervals for each official Danish region
(N = 36,669), compared to the Capital Region of Denmark (reference).
https://doi.org/10.1371/journal.pone.0236322.g002
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from AMI across regions. However, the Danish Society of Cardiology has endorsed interna-
tional guidelines [30, 31], developed by the European Society of Cardiology (ESC), into the
national Danish recommendations to ensure evidence-based and up-to-date treatment
throughout the country. These guidelines are widely adapted by Danish cardiologists and the
implementation of ESC guidelines are likely to contribute to uniform treatment of AMI
patients across regions. In support of equal treatment of AMI patients, Kjærulff et al. [7]
recently found that no geographical inequality among Danish patients who survived the first
28 days after AMI hospitalisation exist. This particular finding indicates uniform treatment of
AMI patients across regions in Denmark, and thereby, that geographical differences in mortal-
ity from AMI are less likely to result from unequal accessibility to diagnostic methods and
treatment across the country. In addition, regional differences in late accessibility to invasive
coronary care units have been examined. Mixed results have been found [32, 33]. However,
the most recent study demonstrated that distance to an invasive coronary care unit was not
associated with survival in out-of-hospital cardiac arrest patients, but hospitalisation at an
invasive coronary care unit improved survival [33].
In line with our findings, indicating uncertainties in the reporting of AMI as cause-of-
death, former studies on the validity of the diagnosis of AMI also found that AMI as cause-of-
death demonstrated lower accuracy compared to hospitalisation data, with a maximum posi-
tive predictive value of 59% [34]
Furthermore, Lowel et al. found that the positive predictive value of AMI was lower for
patients who had less clinical data and test results with electrocardiogram and enzyme level
available [35]. These results support our findings of more uncertainty in diagnosing and
reporting AMI as cause-of-death when limited diagnostic support is present. Contrary to our
Table 2. Trends in mortality rates from acute myocardial infarction by gender, diagnostic support, and place of
death.
2002 2015 Overall change (%) Annual change (%)
Total AMI mortality
Men 123.4 45.6 - 63.0 - 6.56 (95%CI:-7.05; -6.07)
Women 67.4 20.0 -70.3 - 3.70 (95%CI-3.89; —3.52)
Definite AMI
Men 48.4 13.0 - 73.3 - 3.10 (95%CI -3.42; -2.77)
Women 28.7 7.1 - 75.3 - 1.72 (95%CI—1.94; -1.50)
Plausible AMI
Men 34.2 15.5 - 54.7 - 1.48 (95%CI -1.75; -1.22)
Women 15.7 5.0 - 68.2 - 0.81 (95%CI -0.90; -0.73)
Uncertain AMI
Men 40.8 17.0 - 66.1 - 1.98 (95%CI -2.14; -1.82)
Women 23.0 7.8 - 58.3 - 1.17 (95%CI -1.29; -1.04)
Death in hospital
Men 80.7 20.2 -76.3 -5.04 (95%CI -5.60; -4.47)
Women 41.8 9.9 -74.3 -2.63 (95%CI -2.90; -2.33)
Death outside hospital
Men 34.6 17.1 - 50.6 - 1.67 (95%CI -2.09; -1.26)
Women 22.2 7.3 - 67.1 -1.16 (95%CI -1.39; -0.92)
Mortality rates from acute myocardial infarction (AMI) by gender, diagnostic support for fatal AMI, and place of
death describing trends per 100,000 population. Overall change (year: 2002–2015) and annual change are presented
in percentwise change and with 95% confidence intervals for annual change.
https://doi.org/10.1371/journal.pone.0236322.t002
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findings, another Danish study that validated AMI in national registries found relatively high
sensitivity compared to clinical records [19]. However, in line with our findings, they also
found that the predictive value and the sensitivity were higher for admissions compared to
mortality data [19]. Several factors may influence the correctness of death certification.
Among these are incidental changes in coding rules and different use of diagnostic criteria,
diagnostic techniques, and biomarkers over time [36]. Moreover, age, speciality, training, and
skills of certifiers have been found to be important predictors of misclassification [16]. The
quality of research may also be seriously impacted since most databases are not established for
research. Instead, diagnoses and procedures are submitted by physicians and other healthcare
personnel to obtain reimbursement [34].
In the present study, we found substantial inter-regional differences in the proportion of
residents who died outside hospital and, furthermore, that death occurring outside hospital
was significantly associated with fatal AMI outcome without supportive data. Regional differ-
ences in AMI mortality could potentially reflect differences in the degree to which death
occurs outside hospital across regions and general practitioners determining the cause-of-
death at home without support from diagnostic techniques. Differences in mortality structures
Fig 3. Risk of uncertain acute myocardial infarction across regions by place of death. Multivariable multinomial logistic regression model describing risk
(odds ratios), with corresponding 95% confidence intervals, of Uncertain acute myocardial infarction (AMI) compared to all-cause mortality across official
Danish regions, stratified by place of death. Model adjusted for covariates. The Reference in the model was the Capital Region of Denmark.
https://doi.org/10.1371/journal.pone.0236322.g003
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have previously been suggested to be partly attributable to differences between rural and urban
populations [37]. The population in the Capital Region is entirely urban, whereas the urban
population in the North Denmark Region is smaller than the rural population.
There may exist important discontinuity in research projects that rely on the correctness of
cause-specific mortality. Previous studies have identified several problems with cause-specific
mortality statistics across regions [38]. While some causes of death (e.g. traffic accidents) have
somewhat comparable mortality rates across regions, there is a larger degree of geographical
difference in the prevalence of other cause-specific diseases. For some causes, the degree of the
variation is believed to be too large and therefore researchers have previously claimed that the
variation is more likely to be artificial rather than indicative of natural occurence [38]. It is
plausible that the regional variation in fatal AMI observed in this present study partly reflects
variation in coding practice rather than real inter-regional differences in AMI mortality. Our
stratified analysis revealed that when comparing only death outside hospital across regions,
significant regional variation in death from AMI was still present. This particular finding indi-
cates possible regional variation in coding practice among physicians recording cause-of-
death outside hospital. In everyday clinical situations, determining the causal sequence leading
Fig 4. Absolute risk of fatal acute myocardial infarction stratified by region and place of death. Predicted absolute risk of fatal acute myocardial infarction
(AMI), stratified by region and by place of death (Panel A: Death in hospital; Panel B: Death outside hospital). Boxplots show 5%, 25%, 50%, 75%, and 95%
quantiles of differences in predicted absolute risks.
https://doi.org/10.1371/journal.pone.0236322.g004
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to death is not simple, and, as discussed by some researchers, in a number of cases it will be the
most approriate choice for the physician to state that the cause-of-death is unknown, rather
than choosing an unfounded cause [39]. However, when a physician currently reports an
unknown cause-of-death, this statement will result in more time-consuming administrative
procedures involving more institutions. International guidelines for the registration of causes
of death [40] instruct that the cause should be recorded as precisely as possible, even if diag-
nostic support is lacking. Information from the relatives on recent pain in the chest of the
deceased without any other information should, therefore, lead to AMI being reported as the
cause of death. Our findings of a higher decline (overall change) in in-hospital mortality are
consistent with findings from other studies on trends in out-of-hospital deaths due to cardio-
vascular disease [41]. In case of a sustained decline in in-hospital AMI mortality a larger quan-
tity of death certificates completed without support from diagnostic techniques may be
expected prospectively. Inaccurate death certificates impair the precision of national health
information data, reducing the utility for public health decision making and research [1].
Limitations
The strengths of this study included the large sample size, the register-based, and the nation-
wide design of the study. In this way, we lowered the risk of selection bias attributed to geo-
graphic differences in patient characteristics. Furthermore, the retrospective and independent
collection of data lowered the risk of information bias. The inherent weakness of the study
arises from the indirect character of the method applied. As we used nationwide registries to
analyse cause-specific mortality, we can only make indirect assessments of the quality and
validity. Extensive inter-regional variation was present; however, we cannot be sure whether
this is caused by misclassification as a result of lack of diagnostic support or by real differences
in mortality from AMI within the population.
Conclusion
In conclusion, more than one-third of deaths reported as fatal AMI lacked diagnostic support.
Our results strongly indicate that regional differences in AMI mortality are associated with
fatal AMI cases without supportive data. This might result from differences in the degree to
which death occurs outside hospital and general practitioners determining the cause-of-death
at home. These findings emphasise that the use of AMI as a cause-of-death requires attention
to supportive data. We suggest that future studies on fatal AMI should include a stratification
on supportive evidence of the diagnosis.
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